ARTICLE
14 March 2023

Holland & Knight Health Dose: March 7, 2023

HK
Holland & Knight

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
United States Washington Food, Drugs, Healthcare, Life Sciences

Holland & Knight Health Doseis an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • Congress This Week: President to Release FY 2024 Budget Request
  • Healthcare Workforce RFI: Responses Due March 20, 2023
  • Ways and Means Republicans Release Oversight Priorities
  • Senate Advances ASPE Health Nominee
  • Bipartisan Pushback on the DEA's Newly Proposed Rule on Telehealth Policies
  • House Oversight Launches Investigation into PBMs
  • New Prior Authorization Policy Effective on July 1, 2023
  • DSH Proposed Rules
  • MedPAC and MACPAC Public Meetings

Read the full Health DoseĀ»

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More